Ilinca Popp

665 total citations
43 papers, 438 citations indexed

About

Ilinca Popp is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Ilinca Popp has authored 43 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 21 papers in Genetics and 15 papers in Oncology. Recurrent topics in Ilinca Popp's work include Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (16 papers) and Lung Cancer Research Studies (9 papers). Ilinca Popp is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (16 papers) and Lung Cancer Research Studies (9 papers). Ilinca Popp collaborates with scholars based in Germany, United States and Norway. Ilinca Popp's co-authors include Anca-Ligia Grosu, Dan G. Duda, Gabriele Niedermann, Horst Urbach, Carsten Nieder, Angelika Bilger, Philipp T. Meyer, Karl Egger, Thomas Rothe and Wolfgang Weber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ilinca Popp

37 papers receiving 434 citations

Peers

Ilinca Popp
Chan Woo Wee South Korea
Dror Limon Israel
Nelson S. Moss United States
Petr Burkoň Czechia
M. Soike United States
Isabella Zhang United States
M Slavík Czechia
J. Curschmann Switzerland
Whoon Jong Kil United States
Chan Woo Wee South Korea
Ilinca Popp
Citations per year, relative to Ilinca Popp Ilinca Popp (= 1×) peers Chan Woo Wee

Countries citing papers authored by Ilinca Popp

Since Specialization
Citations

This map shows the geographic impact of Ilinca Popp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilinca Popp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilinca Popp more than expected).

Fields of papers citing papers by Ilinca Popp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilinca Popp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilinca Popp. The network helps show where Ilinca Popp may publish in the future.

Co-authorship network of co-authors of Ilinca Popp

This figure shows the co-authorship network connecting the top 25 collaborators of Ilinca Popp. A scholar is included among the top collaborators of Ilinca Popp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilinca Popp. Ilinca Popp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gkika, Eleni, Elke Firat, Sonja Adebahr, et al.. (2025). A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment. Radiotherapy and Oncology. 207. 110889–110889.
2.
Sarria, Gustavo R., Julian Philipp Layer, Egon Dejonckheere, et al.. (2024). Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis. Radiotherapy and Oncology. 197. 110331–110331. 4 indexed citations
3.
Becker, Aline Paixão, Joseph P. McElroy, Amy Webb, et al.. (2024). Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas. Cancers. 16(8). 1516–1516. 1 indexed citations
4.
Popp, Ilinca, Wolfgang Weber, Erika Graf, et al.. (2024). Target Volume Delineation for the Re-Irradiation of Recurrent Glioblastoma: MRI- or PET-Based? Results of the GLIAA Prospective Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S119–S119.
5.
Popp, Ilinca, Wolfgang Weber, Erika Graf, et al.. (2024). Re-irradiation in recurrent glioblastoma: PET- or MRI-based? Results of a prospective randomized clinical trial.. Journal of Clinical Oncology. 42(16_suppl). 2021–2021.
6.
Roohani, Siyer, Felix Ehret, Christoph Fink, et al.. (2024). Gliosarcoma: A Multi‐Institutional Analysis on Clinical Outcomes and Prognostic Factors. Cancer Medicine. 13(22). e70347–e70347. 1 indexed citations
7.
Popp, Ilinca, et al.. (2023). PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?. Cancers. 15(12). 3193–3193. 8 indexed citations
8.
Gkika, Eleni, Elke Firat, Sonja Adebahr, et al.. (2023). Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer. npj Precision Oncology. 7(1). 24–24. 12 indexed citations
9.
Rühle, Alexander, Lennard Halle, Eleni Gkika, et al.. (2023). The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation. European Archives of Oto-Rhino-Laryngology. 280(5). 2605–2616. 4 indexed citations
10.
Popp, Ilinca, Rianne D.W. Vaes, Lotte Wieten, et al.. (2023). Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials. Radiotherapy and Oncology. 190. 110048–110048. 7 indexed citations
12.
Gkika, Eleni, Sonja Adebahr, Tanja Schimek‐Jasch, et al.. (2021). Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies. Cancers. 13(22). 5725–5725. 6 indexed citations
13.
Carles, M., Ilinca Popp, Michael Mix, et al.. (2021). FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?. Radiation Oncology. 16(1). 46–46. 28 indexed citations
14.
Klement, Rainer J., Ilinca Popp, David Kaul, et al.. (2021). Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis. Journal of Neuro-Oncology. 156(2). 407–417. 1 indexed citations
15.
Nieder, Carsten, et al.. (2020). Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA). Radiation Oncology. 15(1). 35–35. 6 indexed citations
16.
Becker, Aline Paixão, Erica H. Bell, S. Jaharul Haque, et al.. (2019). Tumor Heterogeneity in Gliomas – a Histopathology-Targeted Proteomic Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 105(1). E95–E95. 1 indexed citations
17.
Popp, Ilinca, Stefan Bott, Michael Mix, et al.. (2018). Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma. Radiotherapy and Oncology. 130. 121–131. 26 indexed citations
18.
Popp, Ilinca, Anca - Ligia Grosu, Gabriele Niedermann, & Dan G. Duda. (2016). Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications. Radiotherapy and Oncology. 120(2). 185–194. 90 indexed citations
19.
Wieser, Gesche, Ilinca Popp, Rosalba Mansi, et al.. (2014). GRPR antagonist 68Ga-RM2 as PET tracer for imaging prostate cancer: Initial experiences. 55. 17–17. 1 indexed citations
20.
Popp, Ilinca, et al.. (1979). Suppression of immune anti-tumor lymphocytes by macrophages of advanced tumor bearing rats, across a cell impermeable membrane.. PubMed. 26(6). 697–702. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026